The onset of diabetes relative to clinical diagnosis was estimated in Egyptians with noninsulindependent diabetes mellitus (NIDDM) based on the relationship between retinopathy and duration of diabetes. Between July 1992 and October 1993 the Diabetes in Egypt (DIE) Project performed a cross-sectional, population-based survey with clinical and laboratory follow-up to describe the prevalence of microvascular, neuropathic, and macrovascular complications among Egyptians a 20 years of age with diagnosed diabetes, previously undiagnosed diabetes, impaired glucose tolerance, and normal glucose tolerance. The sample of persons with diabetes diagnosed prior to the survey had medical examinations which included a dilated eye examination and retinal photographs. Generalized linear models were used to relate the probability of retinopathy to duration of diabetes. Among 218 persons with diabetes diagnosed prior to the DIE project, 87 (40 %) had diabetic retinopathy. The onset of retinopathy was estimated to occur 2.6 years (p = 0.04) prior to clinical diagnosis. The estimated annual incidence of retinopathy was 5 % and the estimated prevalence at the time of clinical diagnosis of diabetes was 12 %. On the basis of reports that retinopathy does not occur until approximately 5 years after the development of diabetes, the onset of NlDDM was estimated to occur 7.6 years prior to its clinical diagnosis. This estimate of the onset of NIDDM in Egyptians is comparable to other estimates reported for US and Australian populations.
Introduction
Undiagnosed diabetes is an important clinical and public health problem. World-wide, half of all cases of diabetes are undiagnosed.' The onset of non-insulindependent (Type 2) diabetes mellitus (NIDDM) is suspected to precede its clinical diagnosis by several years because diabetic microvascular complications that take years to develop are often present at the time of clinical diagnosis. At clinical diagnosis, as many as 29 ' YO of persons with diabetes have retinopathy,* 8 % have nephr~pathy,~ and 9 ' YO have neuropathy.* Because the microvascular structures in the eye can be directly examined, retinopathy is usually the first of the diabetic microvascular complications detected. Retinopathy is a sensitive and specific indicator that can be used to estimate the duration of NIDDM and retrospectively determine its onset. Nephropathy and neuropathy are generally defined using arbitrary thresholds, and are less sensitive than retinal abnormalities as markers of diabetic microvascular complications.
This study was designed to examine the relationships among clinical diagnosis, duration of diabetes, and presence of retinopathy. The findings can be used to estimate the actual onset of NIDDM. years of age and who used insulin were excluded because they were considered to have IDDM. Fourteen persons had missing data on clinical diagnosis. Additionally, persons with the time since clinical diagnosis >20 years ( n = 47) were excluded because of concerns related to selective mortality. This resulted in a study population of 218 persons.
Logistic regression was used in a preliminary analysis to test if the probability of retinopathy was related to diabetes duration, sex, age, and urban versus rural residence. For the primary analyses we used generalized linear models.' O These are a class of statistical models that includes classical linear models (i.e. least squares regression), log-linear models, probit and logit (i.e. logistic regression) models, and several models for survival data. Specification of a model within this class requires a link function and a probability distribution.
For example, a log link and Poisson distribution is equivalent to a log-linear model. An identity link and normal distribution is equivalent to least squares 338 regression. A logit link and binomial distribution is equivalent to logistic regression. In this study a complementary log-log link and binomial probability distribution is used. The response variable was the presence of retinopathy. The predictor variable was the logarithm of the quantity: number of years diabetes was present after clinical diagnosis plus the duration of diabetes prior to clinical diagnosis. This model has the form In( -In (1 -F(0) Our final generalized linear model, plotted in Figure  1 Factors that might explain the estimated differences among populations include behaviours related to seeking care, access to medical care, physician practices in pursuing the diagnosis of diabetes, the severity of hyperglycaemia, the prevalence of comorbidities which accelerate complications, and variations in racial and ethnic susceptibility to complications. However, the prevalence of retinopathy in populations where studies include persons detected through active case finding, such as population-based surveys, or intense screening activity, will tend to be lower because diabetes is more likely to be detected at an earlier stage, that is, before the clinical diagnosis is made. Caution must be taken in comparing various studies. In the Egyptian population, the prevalence of retinopathy in persons with diabetes first detected through population-based screening and diagnostic testing during the Diabetes in Egypt survey was 15 Yo.
We also estimate a 47 % 10 year incidence rate of retinopathy (5 YO annual incidence). The WESDR" found a 10-year incidence rate of 79 Yo in insulin-taking persons 30 years or older and 6 7 % in non-insulin-taking persons 30 years or older with diabetes. The severity of hyperglycaemia, other comorbidities, and racial ethnic differences may also explain these differences. 
